Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Sep;21(3):673-95, viii.
doi: 10.1016/j.idc.2007.06.006.

Infections in chronic lung diseases

G Iyer Parameswaran  1 , Timothy F Murphy
Affiliations
Review

Infections in chronic lung diseases

G Iyer Parameswaran et al. Infect Dis Clin North Am. 2007 Sep.

Abstract

Chronic lung diseases are prevalent worldwide and cause significant mortality and suffering. This article discusses infections that occur in three chronic lung diseases: chronic obstructive pulmonary disease, bronchiectasis, and cystic fibrosis. Rather than discussing the role of infections as etiology of these diseases, this article focuses on infections that occur in the background of established chronic lung disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Bacterial infection in chronic obstructive pulmonary disease. Exacerbation defined by acquisition of a new strain associated with clinical symptoms of an exacerbation. H infl, H influenzae; M cat, M catarrhalis; P aerug, P aeruginosa, S pneumo, S pneumoniae.
Fig. 2
Fig. 2
Bacterial infection in cystic fibrosis. MRSA, methicillin-resistant S aureus. (From Cystic Fibrosis Foundation, Patient Registry 2004 Annual Report. Bethesda, Maryland; with permission.)
See this image and copyright information in PMC

References

    1. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946. - PubMed
    1. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990–2020. Global Burden of Disease Study. Lancet. 1997;349:1498–1504. - PubMed
    1. Rodriguez-Roisin R. The airway pathophysiology of COPD: implications for treatment. COPD. 2005;2:253–262. - PubMed
    1. Vestbo J., Prescott E., Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996;153:1530–1535. - PubMed
    1. Melton L. Does mucus hypersecretion matter in airway disease? Lancet. 2002;359:1924. - PubMed

MeSH terms